CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Roger Weiss

OPENALEX: A5012668362↗ORCID: 0000-0001-7503-828X↗

Affiliations

Organizations

Brigham and Women's Hospitalauthorship · US Harvard Universityauthorship · US Lemuel Shattuck Hospitalauthorship · US McLean Hospitalauthorship · US

Public evidence

2 connected articles

Impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder: A pilot, double-blind, placebo-controlled, randomized cross-over trial.2023 · Europe PMC Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study.2022 · Europe PMC

Registered research

Connected studies

A Single-arm, Open-label Feasibility Pilot of Cannabidiol as an Adjunct to Sublingual Buprenorphine on Cue-induced Cravings Among Individuals With Opioid Use Disordernct04192370 Cannabidiol on reward-and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder: A Double-blind, Placebo-controlled, Cross-over Trialnct04982029 Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trialnct07148206

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Roger Weiss - Medical Cannabis Research Engine